Vehicle Automation Impact on Drivers (AUTODRIVE)
On the Highway to Autonomous Driving: How is Automation Changing Humans: Investigations of Drivers' Behaviors, Representations and Neural Processes
In the context of ever-increasing automation in surface vehicles, automation impact on drivers will be investigated through three complementary research axes undertaken under simulated driving:
Axe 1 (Cognitive ergonomics), how automation is impacting driving behaviors and visual explorations? Axe 2 (Experimental psychology), how automation is impacting drivers' mental representations of their own driving abilities? Axe 3 (Neuroimaging), how automation is modifying the car driving neural network? And what are drivers' mental representations neural bases? The project tackle both applied and basic research issues using an original experimental neuro ergonomics approach. AUTODRIVE will bring original data on human-machine cooperation, mental representations, cognitive control and brain processes depending on the characteristics of the automation used over a significant period of time (six weeks) on a large sample (N=120) of experienced and inexperienced drivers.
研究概览
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名：Jordan Navarro, MD
- 电话号码：00 33 4 78 77 30 52
- 邮箱：jordan.navarro@univ-lyon2.fr
研究联系人备份
- 姓名：Emanuelle Reynaud, MD
- 电话号码：00 33 4 78 77 24 31
- 邮箱：emanuelle.Reynaud@univ-lyon2.fr
学习地点
-
-
-
Bron、法国
- 招聘中
- Laboratoire d'Etude des Mécanismes Cognitifs (EMC)
-
接触：
- Jordan NAVARRO, PhD
-
副研究员：
- Perrine SEGUIN, MD
-
首席研究员：
- Jordan NAVARRO, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- To be between the ages of 22 and 45 years old
- Having given an informed consent for the study
- Being registered with the French Social Security System
- No driving license for 60 participants
- Driving license for 4 years or more for 60 participants
Exclusion Criteria:
- No signature on the consent form
- Inability to read or write French.
- Neurologic or psychiatric illness, known or revealed during the inclusion visit
- Substance intake ( taking psychoactive medications or recreational drugs) on the day of the experiment
- Noise intolerance
- Need of vision glasses to drive
- Persons under curators or deprived of civil rights or deprived of their freedom
- Unable to fill a questionnaire (severe cognitive troubles)
- Subjects must not have metallic or electronic implants in the body : pacemakers or pacemaker wires, open heart surgery, artificial heart valve, brain aneurysm surgery, middle ear implant, hearing aid, braces or extensive dental work, cataract surgery or lens implant, implanted mechanical or electrical device, or artificial limb or joint o foreign metallic objects in the body (bullets, BBs, pellets, shrapnel, or metalwork fragments) or current or past employment as machinists, welders or metal workers, tattoos near the head or neck regions, permanent makeup
- Claustrophobia
学习计划
研究是如何设计的？
设计细节
- 主要用途：基础科学
- 分配：非随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：UnAssisted (UA)
This term refers to driving a vehicle manually without any vehicle automation technology.
It will serve as a baseline concerning behaviors, representations and neural results associated with unassisted automobile driving.
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
|
实验性的：Assisted (A)
This term refers to driving with warning technology which upon activation sounds an a warning when the vehicle is too close to the edge of the road (off-road warning , Navarro, Mars, & Hoc, 2007; Suzuki & Jansson, 2003) or too close to the vehicle in front of it (anti-collision warning; Lee, McGehee, Brown, & Reyes, 2002).
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
|
实验性的：Shared Control (SC)
This term refers to shared tactical control between the driver and the automated assistive technology, both working simultaneously on the physical trajectory of the vehicle, laterally (Griffiths & Gillespie, 2005; Mulder, Abbink, & Boer, 2012) as well as longitudinal (Adell, Várhelyi, & Hjälmdahl, 2008).
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
|
实验性的：Partly Autonomous (PA)
This term refers to a situation where the lateral and longitudinal control of the driving are delegated to the automated assistive technology.
It consists of a level of automatisation that today is possible to put into application and which often is referred to by the name "Highly Automated Driving" (Navarro, 2018).
In this case, the driver is no longer the one who physically ensures the lateral and longitudinal control of the vehicle, but instead supervises the actions of the automated assistive technology.
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
|
实验性的：Fully Autonomous (FA)
This term refers to a completely automated driving experience.
The on-board technologies take over all the driving tasks for any driving situation.
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
|
实验性的：Any Automation (AA)
This term refers to a situation where the drivers can choose the automation device of their choice among the five types presented above and can change it whenever they think it is good to do so.
|
From no automation of the vehicle to full automation through warnings, shared control and partly automated automation levels.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
BOLD effect
大体时间：Repetition Time (TR) :every 3 seconds, during the 3 fMRI sessions of respectively 1 hour, 0,75 hour and 0,75 hour. fMRI session 2 occurs 3 weeks after fMRI session 1 and 3 weeks before fMRI session 3.
|
Functional magnetic resonance imaging measures brain activity by detecting changes associated with blood flow This technique relies on the fact that cerebral blood flow and neuronal activation are coupled. When an area of the brain is in use, blood flow to that region also increases. The primary form of fMRI uses the blood-oxygen-level dependent (BOLD) contrast in response to an experimental condition (Ogawa, Lee, Kay, & Tank, 1990), allowing researchers to track changes in oxygen consumption on the brain, and therefore brain activity. BOLD effect is computed by assessing the different relaxation times (T1 and T2) in the brain, as T1 and T2 are different in function of regional cerebral blood flows. The outcome will be a change between mean BOLD effect oven session 1 versus session 2 versus session 3. |
Repetition Time (TR) :every 3 seconds, during the 3 fMRI sessions of respectively 1 hour, 0,75 hour and 0,75 hour. fMRI session 2 occurs 3 weeks after fMRI session 1 and 3 weeks before fMRI session 3.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Behavioral changes
大体时间：Two experimental sessions of an hour, one before and one after the six weeks of automated driving. Plus six driving sessions of 0,5 hour, one driving session the first day of each experimental week.
|
Participants will be asked to drive through a variety of driving situations in a driving simulator simulated environment equipped with an eye-tracker. The measure collected will be drivers' behaviors on the steering wheel and pedals as well as their visual behaviors. The outcome will be a change in the number of actions on the steering wheel (a), pedals (b) and gaze dispersion (c) on the visual scene across the time points. |
Two experimental sessions of an hour, one before and one after the six weeks of automated driving. Plus six driving sessions of 0,5 hour, one driving session the first day of each experimental week.
|
合作者和调查者
调查人员
- 首席研究员：Jordan Navarro, MD、: Laboratoire d'Etude des Mécanismes Cognitifs (EMC) -Université Lumière Lyon 2
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 69HCL19_0141
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.